Information Library

Results for: Connect with investigators, regulators and physicians - Product Development & Commercialization

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Quintiles Acquires VCG & Associates and VCG Bio

    Press Release — October 19, 2011 – The acquisition of VCG & Associates and VCG BIO strengthens Quintiles’ comprehensive commercial services in sales and brand solutions, product solutions, product distribution and market access.

  • Quintiles Names New Global Head of Clinical & Data Operations

    Press Release — October 6, 2011 – Quintiles announced that Steven Skolsky has been appointed Global Head of its Clinical & Data Operations (CDO) unit.

  • An Integrated Approach to Biosimilar Development & Commercialization

    White Paper — September 29, 2011
    As the market for biosimilar products continues to grow, many biopharmaceutical companies trying to enter the space are struggling to overcome the unique challenges that developing such products presents.

  • QUINTILES WINS SCRIP AWARDS ‘BEST CLINICAL RESEARCH ORGANIZATION’ FOR SECOND CONSECUTIVE YEAR

    Press Release — November 9, 2010 - For the second consecutive year, Quintiles has received Scrip Awards Best Clinical Research Organization honors based upon judging by an independent panel of prestigious life sciences experts.

  • Targeting Oncology

    Brochure — June 2, 2010
    Learn more about Quintiles leadership in oncology product development and commercialization.

  • Propelling Pediatric Research

    Case Study — April 1, 2010
    Learn how Quintiles' global reach and rigorous research standards dramatically cut recruitment from 4 years to 1 in a childhood immunology study

  • Commercial – Identify, Promote and Prove Treatment Value

    Brochure — April 1, 2010
    Quintiles has built an unmatched suite of commercial competencies that biopharma companies are leveraging for faster market access and sustained success.

  • Alzheimer's Inroads

    Case Study — March 3, 2010
    A global, multi-site Phase III trial required a large number of patients with a specific number of sites and patients at each site.

  • Trumping Expectations

    Case Study — March 1, 2010
    Quintiles sails past recruitment hurdles with tailored approaches that build momentum

  • Orphan Drugs in the U.S.

    Presentation — June 24, 2009
    Presentation by Dr. John Doyle, Market Access Practice Leader, from ISPOR 14th Annual International Meeting 2009(International Society for Pharmacoeconomics and Outcomes Research) on “Orphan Drugs' Market Access in the U.S.”

Page 1 of 2 (12 results)

Subscribe to Email Based on Your Interests

Set preferences